Question

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects

Answer 1

According to Research, the Antitumor activity and biological effects resulting from the administration of Metronomic low-dose oral cyclophosphamide and methotrexate indicated that it was efficacious and low in toxicity.

What is Metronomic low-dose oral cyclophosphamide and methotrexate?

This is a drug which as at 2005 was being used for clinical trials on patients with tumor or cancerous growth.

The treatment also showed that there was a drop in Vascular Endothelial Growth Factor (VEGF).

It is to be noted that there was no noticeable improvements with the addition of thalidomide.

Learn more about antitumor at;
brainly.com/question/17746925
#SPJ1